Michael King - Oct 30, 2023 Form 3 Insider Report for SAB Biotherapeutics, Inc. (SABS)

Signature
/s/ Michael G. King, Jr.
Stock symbol
SABS
Transactions as of
Oct 30, 2023
Transactions value $
$0
Form type
3
Date filed
11/3/2023, 04:40 PM
Next filing
Nov 30, 2023

No securities are beneficially owned.

Remarks:

No securities are beneficially owned.